With an international team of scientists and researchers, GBC is redefining what’s possible in diagnostics, therapeutics, and consumer healthcare. From affordable, high-performance IVD solutions to liquid biopsy innovations and P113 antimicrobial peptide (AMP) therapeutics, we are committed to making precision medicine and better healthcare accessible worldwide
Revolutionizing Lung Cancer Monitoring with CellBio™ a2000: Reliable Isolation of CTCs and CTMs for Precision Oncology
Learn how GBC's CellBio™ a2000 leverages size-based enrichment and dual staining to enable early detection, risk stratification, and therapy monitoring in NSCLC
Find Out More
CellBio™ FX10 Wins 2025 Taiwan Excellence Award
GBC's CellBio™ FX10 CTC system, using patented iFiltration™, delivers >90 % capture rate for circulating tumor cells from minimal blood volumes—earning the 2025 Taiwan Excellence Award for innovation in diagnostics
Find Out More
AI-Powered Kidney Stone Screening: A Breakthrough in Non-Invasive Diagnostics
AI-driven kidney stone screening integrates health check data and machine learning to enable fast, accurate, and non-invasive risk prediction, shaping the future of precision diagnostics
Find Out More
CTC Applications in Sarcoma Research: From Detection to Precision Oncology
Explore how circulating tumor cell (CTC) analysis enhances sarcoma diagnosis, staging, and personalized therapy through non-invasive, real-time insights, advancing precision oncology
Find Out More
CellBio™ Wins Bronze at Taiwan’s National Pharmaceutical Technology & R&D Awards
GBC's CellBio™ platform earns Bronze at the National Pharmaceutical Technology & R&D Awards, recognized for iFiltration™ innovation enabling intact-cell capture and multi-omic insights in liquid biopsy
Find Out More
Exploring Emerging Trends in Medical Technology: Precision Medicine
Discover how GBC is driving innovation in precision medicine with breakthroughs in CTC detection, NGS applications, and automated CellBio™ platforms. Learn more about the future of healthcare technologies
Find Out More
Understanding COVID-19 Variants From Delta to Kraken: How GBC Diagnostics Stay Ahead
Explore the latest COVID-19 variants, from Delta to Omicron's Kraken subvariant, and learn how GBC's GB COVID-19 Ag Rapid Test stays reliable against evolving mutations
Find Out More
Staying Accurate Against Omicron: How GBC’s Rapid Antigen Test Meets the XBB.1.5 “Kraken” Era
Learn how GBC's GB COVID-19 Ag Rapid Test remains reliable against Omicron, including XBB.1.5 (Kraken), and why serial testing matters
Find Out More
P113 Antimicrobial Peptide Transforms Oral Care | oh care® Science-Backed Solutions for Family Health
Powered by GBC's patented P113 antimicrobial peptide, the oh care® oral care series delivers clinically proven, alcohol- and fluoride-free products for safe, everyday family use
Find Out More
The Future of Molecular Diagnostics: Driving Precision Medicine Forward
Explore how GBC is shaping the future of molecular diagnostics with innovations in real-time PCR, automated testing platforms, and integrated workflows. Learn how these technologies enable faster, more accurate, and more accessible diagnostics for personalized healthcare
Find Out More
AI-Powered Cervical Cancer Screening
GBC integrates thin-layer smears with AI deep learning to automate cervical cancer cell screening, improving accuracy, efficiency, and scalability in digital pathology.
Find Out More
Pathogen Detection Methods: From Rapid Antigen to PCR
Learn how pathogens are identified, from antigen-based rapid tests to highly accurate RT-PCR, and how GBC applies these methods for COVID-19 and beyond
Find Out More
Ct Value Explained: What It Means for COVID-19 Testing
Learn what Ct values represent in qRT-PCR testing, their link to viral load, and factors affecting interpretation in COVID-19 diagnostics
Find Out More
RAPID TEST vs. PCR: Understanding COVID-19 Detection Methods
Explore the differences between COVID-19 rapid antigen (lateral flow) tests and RT-PCR, including how they work, sensitivity, specificity, and practical use cases
Find Out More